intellectual property

DrNatura and DrFlores are not Confusingly Similar Trademarks for Herbal Supplements

Guest Trademark Post: Judith L. Grubner, Partner, Arnstein & Lehr, LLP Alaven Consumer Healthcare, Inc. manufactures and sells Colonix non-prescription herbal supplements and intestinal cleansers under its house brand DrNatura.  Alaven sued DrFloras LLC for trademark infringement, unfair competition, false advertising and other claims for using the trademark DrFloras for similar products.  The federal district [...]

Need help registering a trademark?

If you are an established supplement company looking for assistance with an intellectual property issue, or a brand new supplement firm trying to break into the market, we are here to help! We often receive inquiries from companies looking for assistance with trademark matters.  For this very reason, we created a new form for use [...]

Arnstein & Lehr Intellectual Property Law Newsletter Winter 2009

Arnstein & Lehr Intellectual Property Law Newsletter Winter 2009

Summer 2009 Arnstein & Lehr Intellectual Property Newsletter Now Available

The Intellectual Property Newsletter from Arnstein & Lehr’s Intellectual Property Practice Group discusses several recent cases that effect law pertaining to trademarks and other IP issues.  The newsletter was written by Partners Judith Grubner and Joel Rothman.  To read the latest issue, click here.

Winfrey’s Harpo and Illinois AG sue acai marketers

Dr. Mehmet Oz may have bid farewell to the Oprah Winfrey Show in May, but the pair are back together again, this time as plaintiffs in a lawsuit filed in federal court in New York against dozens of companies they claim used their images and false endorsements to market acai supplement products. Last year, Oz [...]

Placebos cloud results of clinical trials, medical practice

Placebos seem to make a difference in research and clinical practice. For that reason, testimonials and open-label trial results should never be provided as sole evidence of efficacy when a product marketing campaign is challenged by a regulatory authority.